Search research articles
Contact Us
Filters
Showing results (11-20 of 123) with videos related to
Page
of 13
Sort By:
Current Opinion in Immunology
|
October 1, 2022
Editorial overview: The life and times of peptide-MHC
Andrea J Sant, Lawrence J Stern
Biochemistry
|
October 19, 2005
Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping
Gregory J Carven, Lawrence J Stern
Current Opinion in Immunology
|
January 28, 2014
HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation
Elizabeth D Mellins, Lawrence J Stern
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2006
CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement
Jennifer D Stone, Lawrence J Stern
Plos One
|
July 3, 2018
The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release
Maria Pia Negroni, Lawrence J Stern
Immunology
|
February 7, 2008
Class II major histocompatibility complex tetramer staining: progress, problems, and prospects
Sabrina S Vollers, Lawrence J Stern
Immunogenetics
|
November 14, 2018
Class II MHC antigen processing in immune tolerance and inflammation
Mollie M Jurewicz, Lawrence J Stern
Immunology Letters
|
January 2, 2008
GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells
Sriram Chitta, Laura Santambrogio, Lawrence J Stern
Current Pharmaceutical Design
|
October 29, 2009
HLA-DR: molecular insights and vaccine design
Lawrence J Stern, J Mauricio Calvo-Calle
Current Opinion in Immunology
|
December 13, 2005
MHC class II compartment subtypes: structure and function
Lawrence J Stern, Ilaria Potolicchio, Laura Santambrogio
Page
of 13
Search research articles
Search
Showing results (11-20 of 123) with videos related to
Sort By:
Page
of 13
Current Opinion in Immunology
|
October 1, 2022
Editorial overview: The life and times of peptide-MHC
Andrea J Sant, Lawrence J Stern
Biochemistry
|
October 19, 2005
Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping
Gregory J Carven, Lawrence J Stern
Current Opinion in Immunology
|
January 28, 2014
HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation
Elizabeth D Mellins, Lawrence J Stern
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2006
CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement
Jennifer D Stone, Lawrence J Stern
Plos One
|
July 3, 2018
The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release
Maria Pia Negroni, Lawrence J Stern
Immunology
|
February 7, 2008
Class II major histocompatibility complex tetramer staining: progress, problems, and prospects
Sabrina S Vollers, Lawrence J Stern
Immunogenetics
|
November 14, 2018
Class II MHC antigen processing in immune tolerance and inflammation
Mollie M Jurewicz, Lawrence J Stern
Immunology Letters
|
January 2, 2008
GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells
Sriram Chitta, Laura Santambrogio, Lawrence J Stern
Current Pharmaceutical Design
|
October 29, 2009
HLA-DR: molecular insights and vaccine design
Lawrence J Stern, J Mauricio Calvo-Calle
Current Opinion in Immunology
|
December 13, 2005
MHC class II compartment subtypes: structure and function
Lawrence J Stern, Ilaria Potolicchio, Laura Santambrogio
Page
of 13